Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Louisiana State University Health Sciences Center in New Orleans
This study proposes the use of a newly developed experimental radioactive dye (radiolabeled methylene blue). On the day of surgery, the patient receives a single injection of the experimental radioactive dye after anesthesia. The injection will be in the location around the breast tumor. The surgeon makes a small cut in the armpit on the side of the cancer and is able to locate the lymh nodes that collect drainage from the cancerous area by detecting lymph nodes with higher radioactivity using a hand-held detector (a Geiger counter-like device) and/or visually identifying lymph nodes stained blue by the dye. These lymph nodes are then removed and analyzed by pathologists for the presence of cancer.
Age
18–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Stage 0,I, II breast cancer
Clinical node status N0, N1
No know allergy to iodine, lymphazurin or methylene blue dyes
You may not be if
Patient cannot be pregnant or nursing
Prisoners will not be eligible
Women under the age of 18 will not be eligible
Patients with a known allergy to iodine or methylene blue or lymphazurin blue dyes
Clareo Health | Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)
